Toonkel L M, Fix I, Jacobson L H, Wallach C B
Int J Radiat Oncol Biol Phys. 1983 Jan;9(1):33-9. doi: 10.1016/0360-3016(83)90205-5.
One hundred twenty-one patients with local or regional recurrence of carcinoma of the breast without evidence of distant metastases were treated with megavoltage radiation therapy. All patients had radical or modified radical mastectomy as their initial treatment. The 10 year survival probability of this group of patients is 26%, with a local control probability of 46%. Within this group of patients with recurrent disease, factors found to be associated with a poorer prognosis include peripheral nodal recurrence, advanced initial disease stage and short disease free interval. Contrary to expectation, patients with recurrence within the mastectomy scar (as opposed to chest wall recurrence wide of the scar) or a history of previous radiotherapy had poorer local control rates (although not statistically significant), without effect upon overall survival. Comprehensive radiation therapy (peripheral lymphatic plus chest wall) enhanced the local control rate for the entire group and the survival probability for patients with isolated chest wall recurrence compared with limited radiation therapy fields. (Five year survival probability: chest wall irradiation only = 27%; chest wall and peripheral lymphatic = 54%). Patients given systemic therapy at the time of local recurrence showed no survival benefit. Aggressive, comprehensive radiation therapy is indicated for locally recurrent breast cancer. More effective systemic therapy is needed, especially for higher risk patients.
121例局部或区域复发的乳腺癌患者,无远处转移证据,接受了兆伏级放射治疗。所有患者最初均接受了根治性或改良根治性乳房切除术。该组患者的10年生存概率为26%,局部控制概率为46%。在这组复发疾病患者中,发现与预后较差相关的因素包括外周淋巴结复发、初始疾病分期较晚和无病间期短。与预期相反,乳房切除疤痕内复发(与远离疤痕的胸壁复发相反)或既往有放疗史的患者局部控制率较低(尽管无统计学意义),但对总生存无影响。与有限的放疗野相比,综合放疗(外周淋巴加胸壁)提高了整个组的局部控制率以及孤立胸壁复发患者的生存概率。(五年生存概率:仅胸壁照射 = 27%;胸壁和外周淋巴 = 54%)。局部复发时接受全身治疗的患者未显示出生存获益。对于局部复发的乳腺癌,建议采用积极的综合放疗。需要更有效的全身治疗,尤其是对于高危患者。